Anti-Borrelia recombinant IgG + VlsE (CSF) ELISA kit, 96 tests

The ELISA-VIDITEST anti-Borrelia recombinant IgG + VlsE (CSF) kit is intended for the detection of IgG antibodies to the pathogenic borrelia strains (B. afzelii, B. garinii and B. burgdorferi sensu stricto) in human serum or plasma, cerebrospinal fluid and synovial fluid. The detection of antibodies is one of the laboratory tests that help to diagnose Lyme disease.

This kit is a solid-phase immunoanalytical test. The polystyrene strips are coated with the mixture of recombinant antigens. Anti-borrelia antibodies in serum samples bind to the immobilized antigens. The serum antibodies that do not bind are washed away and those that formed complexes with the antigens are later recognized by animal anti-human IgG antibodies labeled with horseradish peroxidase. The presence of labeled antibodies is revealed by an enzymatic reaction with a chromogenic substrate. Negative sera do not react. A mild change in color, if present, may be attributed to the reaction background.